These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38825234)

  • 1. Mechanical Characterization of Vial Strain During Freezing and Thawing Operations Using Amorphous Excipients.
    Strongrich A; Flynn I; Bhatnagar B; Shalaev E; Tchessalov S
    J Pharm Sci; 2024 May; ():. PubMed ID: 38825234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cations and anions on glass transition temperatures in excipient solutions.
    Nesarikar VV; Nassar MN
    Pharm Dev Technol; 2007; 12(3):259-64. PubMed ID: 17613889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic studies of glass vial breakage for frozen formulations. I. Vial breakage caused by crystallizable excipient mannitol.
    Jiang G; Akers M; Jain M; Guo J; Distler A; Swift R; Wadhwa MV; Jameel F; Patro S; Freund E
    PDA J Pharm Sci Technol; 2007; 61(6):441-51. PubMed ID: 18410045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystallization of mannitol below Tg' during freeze-drying in binary and ternary aqueous systems.
    Pyne A; Surana R; Suryanarayanan R
    Pharm Res; 2002 Jun; 19(6):901-8. PubMed ID: 12134964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Mechanism of Glass Delamination in Type 1A Borosilicate Vials Containing Frozen Protein Formulations.
    Jiang G; Goss M; Li G; Jing W; Shen H; Fujimori K; Le L; Wong L; Wen ZQ; Nashed-Samuel Y; Riker K; Germansderfer A; Tsang P; Ricci M
    PDA J Pharm Sci Technol; 2013; 67(4):323-35. PubMed ID: 23872443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulations of sugars with amino acids or mannitol--influence of concentration ratio on the properties of the freeze-concentrate and the lyophilizate.
    Lueckel B; Bodmer D; Helk B; Leuenberger H
    Pharm Dev Technol; 1998 Aug; 3(3):325-36. PubMed ID: 9742553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic studies of glass vial breakage for frozen formulations. II. Vial breakage caused by amorphous protein formulations.
    Jiang G; Akers M; Jain M; Guo J; Distler A; Swift R; Wadhwa MV; Jameel F; Patro S; Freund E
    PDA J Pharm Sci Technol; 2007; 61(6):452-60. PubMed ID: 18410046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of the kinetics of protein unfolding in viscous systems and implications for protein stability in freeze-drying.
    Tang XC; Pikal MJ
    Pharm Res; 2005 Jul; 22(7):1176-85. PubMed ID: 16028019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of freeze/thaw-related quality attributes of a liquid biopharmaceutical formulation: the role of saccharide excipients.
    Zhou R; Schlam RF; Yin S; Gandhi RB; Adams ML
    PDA J Pharm Sci Technol; 2012; 66(3):221-35. PubMed ID: 22634588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Freeze-concentration separates proteins and polymer excipients into different amorphous phases.
    Izutsu K; Kojima S
    Pharm Res; 2000 Oct; 17(10):1316-22. PubMed ID: 11145240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vial breakage during freeze-drying: crystallization of sodium chloride in sodium chloride-sucrose frozen aqueous solutions.
    Milton N; Gopalrathnam G; Craig GD; Mishra DS; Roy ML; Yu L
    J Pharm Sci; 2007 Jul; 96(7):1848-53. PubMed ID: 17299763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrolyte-induced changes in glass transition temperatures of freeze-concentrated solutes.
    Her LM; Deras M; Nail SL
    Pharm Res; 1995 May; 12(5):768-72. PubMed ID: 7479566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fundamentals of freeze-drying.
    Nail SL; Jiang S; Chongprasert S; Knopp SA
    Pharm Biotechnol; 2002; 14():281-360. PubMed ID: 12189727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Freeze concentration during freezing: How does the maximally freeze concentrated solution influence protein stability?
    Seifert I; Friess W
    Int J Pharm; 2020 Nov; 589():119810. PubMed ID: 32866649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amorphous-Amorphous Phase Separation of Freeze-Concentrated Protein and Amino Acid Excipients for Lyophilized Formulations.
    Izutsu KI; Yoshida H; Shibata H; Goda Y
    Chem Pharm Bull (Tokyo); 2016; 64(12):1674-1680. PubMed ID: 27904076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Through-vial impedance spectroscopy of critical events during the freezing stage of the lyophilization cycle: the example of the impact of sucrose on the crystallization of mannitol.
    Arshad MS; Smith G; Polygalov E; Ermolina I
    Eur J Pharm Biopharm; 2014 Aug; 87(3):598-605. PubMed ID: 24825125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Method development and analysis of the water content of the maximally freeze concentrated solution suitable for protein lyophilisation.
    Seifert I; Bregolin A; Fissore D; Friess W
    Eur J Pharm Biopharm; 2020 Aug; 153():36-42. PubMed ID: 32526356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glass Transition and Re-Crystallization Phenomena of Frozen Materials and Their Effect on Frozen Food Quality.
    Roos YH
    Foods; 2021 Feb; 10(2):. PubMed ID: 33670558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of glass transition temperatures in freeze concentrated solutions of non-electrolytes by electrical thermal analysis.
    Her LM; Jefferis RP; Gatlin LA; Braxton B; Nail SL
    Pharm Res; 1994 Jul; 11(7):1023-9. PubMed ID: 7937543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Freeze-Drying Above the Glass Transition Temperature in Amorphous Protein Formulations While Maintaining Product Quality and Improving Process Efficiency.
    Depaz RA; Pansare S; Patel SM
    J Pharm Sci; 2016 Jan; 105(1):40-9. PubMed ID: 26580140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.